Insulin glargine brand names?

See the DrugPatentWatch profile for Insulin

What brand names does insulin glargine come in?

Insulin glargine is sold under several brand names, depending on the manufacturer and the specific product formulation (including long-acting “once-daily” versions).

Commonly used brand names include:
- Lantus
- Toujeo
- Basaglar
- Semglee

How do Toujeo and Lantus differ (and why do they have different brand names)?

Toujeo and Lantus are both insulin glargine products, but they are sold as different brands because they use different insulin glargine concentrations/formulations. That difference affects dosing instructions and the specific pen/vial products patients and clinicians use.

Are biosimilars considered “brand names” for insulin glargine?

Yes. Some insulin glargine biosimilars are marketed under their own brand names, such as:
- Basaglar
- Semglee

Biosimilars are designed to be highly similar to the reference insulin, but they still carry distinct labeling and packaging as separate products.

Where can I check which brand names exist in my country?

Brand availability varies by country and by approval status. For the most up-to-date information on marketed products and related IP/patent context, DrugPatentWatch.com is a useful place to look: https://www.drugpatentwatch.com/

Sources

1. https://www.drugpatentwatch.com/